Protalix BioTherapeutics (PLX) Misses Q1 EPS by 8c
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.43 --0%
EPS Growth %: +400.0%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
NSLR, OCTV, ACB, More
EPS Growth %: +400.0%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
NSLR, OCTV, ACB, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported Q1 EPS of ($0.05), $0.08 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $10.11 million versus the consensus estimate of $21.6 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Four key things investors will watch in Nvidia's earnings next week
- AMCON Distributing to dual-list on NYSE Texas exchange
- SUNation Energy Q2 revenue falls 38% after solar tax credit expires
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
